Limits...
Effects of soft bracing or taping on a lateral ankle sprain: a non-randomised controlled trial evaluating recurrence rates and residual symptoms at one year.

Kemler E, van de Port I, Schmikli S, Huisstede B, Hoes A, Backx F - J Foot Ankle Res (2015)

Bottom Line: This study aimed to compare the effects of four weeks of soft bracing or taping following acute lateral ankle ligamentous sprain (ALALS) on sprain recurrence rates and residual symptoms at one year.Baseline characteristics did not differ appreciably between the treatment groups.ISRCTN92030205.

View Article: PubMed Central - PubMed

Affiliation: Department of Rehabilitation, Nursing Science and Sport, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, PO Box 85500, 3508 GA The Netherlands ; Consumer Safety Institute, Amsterdam, The Netherlands.

ABSTRACT

Background: After sustaining an ankle sprain, taping is often the standard treatment in primary care. Ankle braces are sometimes used as an alternative. This study aimed to compare the effects of four weeks of soft bracing or taping following acute lateral ankle ligamentous sprain (ALALS) on sprain recurrence rates and residual symptoms at one year.

Methods: In this pragmatic, non-randomised controlled trial, 157 adult participants with an ALALS caused by an inversion trauma were alternately allocated to a four week treatment with a soft brace (intervention group) or a four week treatment with ankle tape (control group) in order of presentation. The primary outcome was the 1-year incidence of the self-reported recurrence of ALALS. The secondary outcome was the occurrence of residual symptoms.

Results: Baseline characteristics did not differ appreciably between the treatment groups. Thirteen patients (17%) in the brace group reported a re-injury versus 11 patients (14%) treated with tape, corresponding to a risk difference of 3.1% (relative risk 1.2, 95% CI 0.6 to 2.6). Cox regression analysis showed a hazard ratio of self-reported ankle sprain recurrence within 52 weeks in the brace group compared to the tape group of 0.9 (95% CI 0.4 to 1.9). After one year, patients in the brace group had poorer scores on the manual anterior ankle test, corresponding to a risk difference of 15.4% (RR 2.4, 95% CI 1.1 to 5.0).

Conclusion: ALALS recurrences and residual symptoms appear to be similar at one year when an ALALS is treated with four weeks of soft bracing or taping.

Trial registration: ISRCTN92030205.

No MeSH data available.


Related in: MedlinePlus

Push Med ankle brace.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4404115&req=5

Fig1: Push Med ankle brace.

Mentions: The intervention group received instructions from the sports physician about using and applying the soft brace. The soft brace (Push® med Ankle Brace (Nea International bv)) [24] is based on the principles of the functional tape bandage (Figure 1). Participants were instructed to wear the soft brace for four weeks, except for at night and when taking a shower.Figure 1


Effects of soft bracing or taping on a lateral ankle sprain: a non-randomised controlled trial evaluating recurrence rates and residual symptoms at one year.

Kemler E, van de Port I, Schmikli S, Huisstede B, Hoes A, Backx F - J Foot Ankle Res (2015)

Push Med ankle brace.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4404115&req=5

Fig1: Push Med ankle brace.
Mentions: The intervention group received instructions from the sports physician about using and applying the soft brace. The soft brace (Push® med Ankle Brace (Nea International bv)) [24] is based on the principles of the functional tape bandage (Figure 1). Participants were instructed to wear the soft brace for four weeks, except for at night and when taking a shower.Figure 1

Bottom Line: This study aimed to compare the effects of four weeks of soft bracing or taping following acute lateral ankle ligamentous sprain (ALALS) on sprain recurrence rates and residual symptoms at one year.Baseline characteristics did not differ appreciably between the treatment groups.ISRCTN92030205.

View Article: PubMed Central - PubMed

Affiliation: Department of Rehabilitation, Nursing Science and Sport, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, PO Box 85500, 3508 GA The Netherlands ; Consumer Safety Institute, Amsterdam, The Netherlands.

ABSTRACT

Background: After sustaining an ankle sprain, taping is often the standard treatment in primary care. Ankle braces are sometimes used as an alternative. This study aimed to compare the effects of four weeks of soft bracing or taping following acute lateral ankle ligamentous sprain (ALALS) on sprain recurrence rates and residual symptoms at one year.

Methods: In this pragmatic, non-randomised controlled trial, 157 adult participants with an ALALS caused by an inversion trauma were alternately allocated to a four week treatment with a soft brace (intervention group) or a four week treatment with ankle tape (control group) in order of presentation. The primary outcome was the 1-year incidence of the self-reported recurrence of ALALS. The secondary outcome was the occurrence of residual symptoms.

Results: Baseline characteristics did not differ appreciably between the treatment groups. Thirteen patients (17%) in the brace group reported a re-injury versus 11 patients (14%) treated with tape, corresponding to a risk difference of 3.1% (relative risk 1.2, 95% CI 0.6 to 2.6). Cox regression analysis showed a hazard ratio of self-reported ankle sprain recurrence within 52 weeks in the brace group compared to the tape group of 0.9 (95% CI 0.4 to 1.9). After one year, patients in the brace group had poorer scores on the manual anterior ankle test, corresponding to a risk difference of 15.4% (RR 2.4, 95% CI 1.1 to 5.0).

Conclusion: ALALS recurrences and residual symptoms appear to be similar at one year when an ALALS is treated with four weeks of soft bracing or taping.

Trial registration: ISRCTN92030205.

No MeSH data available.


Related in: MedlinePlus